Research Alliance Corp. II Will Redeem Public Shares Nov 28, 2022 05:16PM
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility Apr 28, 2021 09:07AM
Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Closing of $149.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option to Purchase Mar 22, 2021 02:30PM
IPO for SPAC Research Alliance Corp. II (RACB) Opened at $10.22 Mar 18, 2021 11:40AM